West Asia War Drives Up India's Medical Supply Chain Costs by 10-50%

The West Asia war has increased India's medical device costs by 10-50%, affecting products from syringes to MRI scanners. Disruptions to global shipping, rising energy prices, and petrochemical costs are impacting raw materials like plastics, packaging, and critical components. While India has domestic manufacturing initiatives, a significant upstream dependency on imported materials and components persists, risking localized shortages if current inventory buffers are depleted. Industry bodies are urging interventions to stabilize the supply chain.

The ongoing conflict in West Asia is significantly impacting India's medical device supply chain, leading to cost increases ranging from 10 to 50 percent across various product categories, according to the Andhra Pradesh MedTech Zone (AMTZ). High-volume consumables such as syringes and catheters have seen a 40-50 percent rise in raw material costs, driven by increased polypropylene and PVC prices, coupled with a 15-25 percent hike in packaging expenses. Advanced imaging systems like MRI machines face helium supply disruptions, and CT systems experience component import delays, pushing installation timelines back. The conflict has disrupted global shipping routes, escalating energy costs and, consequently, the price of petrochemical feedstocks vital for India's medical device and pharmaceutical industries. Component lead times for ventilators and oxygen concentrators have also increased by 20-30 percent. While domestic manufacturing has grown through initiatives like the Production Linked Incentive (PLI) Scheme, a 30-40 percent upstream dependency on specialty materials and electronics remains. Manufacturers are currently operating with only two to four weeks of inventory, raising the risk of localized shortages to 60-70 percent if disruptions persist. Industry bodies, including AiMeD and FOPE, have flagged these concerns, prompting the Ministry of Finance to announce a customs duty exemption on critical petrochemical products. Proposed solutions include increasing inventory buffers to six to eight weeks, diversifying material sourcing across multiple geographies, entering longer-term supply agreements, and adopting low-helium MRI technologies to enhance resilience.